STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 52 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $620,000 | – | 124,544 | – | 0.32% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,394,994 | $12,948,000 | 44.18% |
| Vivo Capital, LLC | 3,000,000 | $7,200,000 | 2.37% |
| Opaleye Management Inc. | 1,160,000 | $2,784,000 | 1.64% |
| Granite Point Capital Management, L.P. | 606,607 | $1,456,000 | 1.16% |
| Boxer Capital, LLC | 940,000 | $2,256,000 | 0.87% |
| RA Capital Management | 2,279,099 | $5,470,000 | 0.78% |
| Broadfin Capital, LLC | 2,894,581 | $6,947,000 | 0.77% |
| NEA Management Company, LLC | 4,141,308 | $9,939,000 | 0.40% |
| Tredje AP-fonden | 909,581 | $2,183,000 | 0.09% |
| Anson Funds Management LP | 92,219 | $221,000 | 0.07% |